Thumzup Currently Holds 19.106 BTC with a Market Value of Approximately $1.8 Million as of May 4, 2025 The Company's Board of Directors has Authorized Thumzup to Hold Up to 90% of its Liquid Assets in Bitcoin Under its BTC Reserve Strategy LOS ANGELES, May 5, 2025 /PRNewswire/ -- Thumzup Media Corporation ("Thumzup" or the "Company") (Nasdaq: TZUP), an emerging leader in social media branding and programmatic marketing solutions, today announced that it has filed a "universal shelf" registration statement o ...

It is not surprising that before an earnings season, every investor looks for stocks that can beat market expectations. This is because investors always try to position themselves ahead of time and look to tap stocks that are high-quality in nature.In this regard, we ran a screener that yielded stocks Fox (FOXA) , Newmont (NEM) , Affirm (AFRM) , HealthStream (HSTM) and Iridium Communications (IRDM) as the likely winners on the earnings beat potential.Why Is a Positive Earnings Surprise So Important?Historic ...

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:GeneDx Holdings Corp. (WGS) : This genomics-related diagnostic and information services company has seen the Zacks Consensus Estimate for its current year earnings increasing 12.4% over the last 60 days.NatWest Group plc (NWG) : This banking and financial services company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.Herbalife Nutrition Ltd. (HLF) : This company that offers hea ...

BioCryst Pharmaceuticals (BCRX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 100%. A quarter ago, it was expected that this drugmaker would post a loss of $0.06 per share when it actually produced a loss of $0.13, delivering a surprise of -116.67%.Over the last four quarters, the company ha ...

It’s the question that dominates markets today: how deep will the recession be, and when will stocks return to growth mode? In the confusing blitz of tariffs and reprieves issued over the last few weeks, stocks have joltedWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular contributor on Seeki ...

"Project development is on track; We picked up some strong tailwinds in Q1"LOS ANGELES, May 5, 2025 /PRNewswire/ -- Cadiz, Inc. (NASDAQ: CDZI / CDZIP) ("Cadiz," the "Company"), a California water solutions company, today issued a letter to shareholders from Chairman and Chief Executive Officer Susan Kennedy with a lookback on the first quarter.----- Cadiz Shareholder Letter Development Schedule Fellow Shareholders, In the last six months our team has been at work behind the scenes, navigating the ups, ...

SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) reported its fourth-quarter 2024 earnings, missing analyst expectations and prompting a significant downward revision of its price target by at least one firm. The company is also facing a securities class action lawsuit alleging improper accounting. Hagens Berman is investigating the alleged claims and urges Maravai investors who suffered substantial losses to submit your losses now. Class Period: Aug. 7, 202 ...

Three-year, $3 million investment will focus on expanding care, training clinicians, and proven programs fostering wellness and social connection NEW YORK, May 5, 2025 /PRNewswire/ -- Bread Financial® (NYSE: BFH) and the Bob Woodruff Foundation announced today that the tech-forward financial services company and the leading nonprofit organization supporting veterans will embark on a multiyear mission to improve the mental health of children in military families. Bread Financial's $3 million investment over ...

I've been investing my own money in the stock market for a quarter of century. I've written over 1,700 articles for this site over the last 14 years, and another couple of thousand elsewhere. I've listened toI've been contributing to Seeking Alpha and other investment websites since 2011, with a general (though far from rigid) focus on value over growth. I got my Series 7 and 63 back in 1999, and watched the dot-com bubble peak and then burst in real time at a small, tech-focused retail brokerage in NYC.Ana ...

Ocular Therapeutix (OCUL) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -27.59%. A quarter ago, it was expected that this biotechnology company would post a loss of $0.24 per share when it actually produced a loss of $0.29, delivering a surprise of -20.83%.Over the last four quarters, the c ...